Straumann Holding AG (STMN)
Straumann Holding AG engages in the provision implant, restorative, and regenerative dentistry solutions to dental professionals and dental laboratories around the world. It specializes in development and manufacture of dental implants, instruments, prosthetics and tissue regeneration products for tooth replacement, and restoration solutions to prevent tooth loss. It operates through the following segments: Sales CE, Sales WE, Sales NAM, Sales APAC, Sales LATAM, and Operations. The Sales CE segment engages in the distribution businesses in Germany, Switzerland, Austria, Hungary and the Czech Republic, as well as the business with European, African and Middle Eastern. The Sales WE segment involves the distribution businesses in Scandinavia, the United Kingdom, France, the Benelux countries, Iberia, and Italy. The Sales NAM segment comprises distribution businesses in the United States and Canada. The Sales APAC segment refers to the distribution businesses in Japan, China, Korea, Australia, and New Zealand, as well as the business with Asian distributors. The Sales LATAM segment comprises distribution businesses in Brazil and Mexico, as well as the business with Latin American distributors. The Operations segment contains the global manufacturing network, which includes production of implants, regenerative and CADCAM products as well as all corporate logistics functions. The company was founded by Reinhard Straumann in 1954 and is headquartered in Basel, Switzerland.
|Market Price at 21-11-2017||SFr. 726.00|
|Price to Earnings Ratio||33.27|
|Market Capitalisation||SFr. 11'528.14 (million)|
|Return on Equity (ROE)||29.66%|